Date published: 2025-10-9

1-800-457-3801

SCBT Portrait Logo
Seach Input

4-IPP (CAS 41270-96-6)

0.0(0)
Write a reviewAsk a question

See product citations (3)

Alternate Names:
4-Iodo-6-phenylpyrimidine; MIF Antagonist III
Application:
4-IPP is an inhibitor of macrophage migration inhibitor factor
CAS Number:
41270-96-6
Molecular Weight:
282.08
Molecular Formula:
C10H7IN2
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

4-IPP is an inhibitor of macrophage migration inhibitor factor (MIF). The mode of action relies on the inactivation of biological and catalytic MIF functions. In human lung adenocarcinoma cell lines, 4-IPP may act to inhibit independent migration and anchorage in vitro.


4-IPP (CAS 41270-96-6) References

  1. A novel, macrophage migration inhibitory factor suicide substrate inhibits motility and growth of lung cancer cells.  |  Winner, M., et al. 2008. Cancer Res. 68: 7253-7. PMID: 18794110
  2. Analysis of endogenous ATP analogs and mevalonate pathway metabolites in cancer cell cultures using liquid chromatography-electrospray ionization mass spectrometry.  |  Jauhiainen, M., et al. 2009. J Chromatogr B Analyt Technol Biomed Life Sci. 877: 2967-75. PMID: 19665949
  3. Modeling of ultrasonic degradation of non-volatile organic compounds by Langmuir-type kinetics.  |  Chiha, M., et al. 2010. Ultrason Sonochem. 17: 773-82. PMID: 20388590
  4. Pharmacological inhibition of macrophage migration inhibitory factor interferes with the proliferation and invasiveness of squamous carcinoma cells.  |  Kindt, N., et al. 2013. Int J Oncol. 43: 185-93. PMID: 23677331
  5. Targeting distinct tautomerase sites of D-DT and MIF with a single molecule for inhibition of neutrophil lung recruitment.  |  Rajasekaran, D., et al. 2014. FASEB J. 28: 4961-71. PMID: 25016026
  6. 4-IPP, a selective MIF inhibitor, causes mitotic catastrophe in thyroid carcinomas.  |  Varinelli, L., et al. 2015. Endocr Relat Cancer. 22: 759-75. PMID: 26206776
  7. Macrophage migration inhibitory factor (MIF) is rendered enzymatically inactive by myeloperoxidase-derived oxidants but retains its immunomodulatory function.  |  Dickerhof, N., et al. 2015. Free Radic Biol Med. 89: 498-511. PMID: 26453918
  8. Macrophage migration inhibitory factor - a therapeutic target in gallbladder cancer.  |  Subbannayya, T., et al. 2015. BMC Cancer. 15: 843. PMID: 26530123
  9. MIF inhibition reverts the gene expression profile of human melanoma cell line-induced MDSCs to normal monocytes.  |  Waigel, S., et al. 2016. Genom Data. 7: 240-2. PMID: 26981417
  10. Role of Myeloma-Derived MIF in Myeloma Cell Adhesion to Bone Marrow and Chemotherapy Response.  |  Zheng, Y., et al. 2016. J Natl Cancer Inst. 108: PMID: 27381622
  11. D-dopachrome tautomerase is over-expressed in pancreatic ductal adenocarcinoma and acts cooperatively with macrophage migration inhibitory factor to promote cancer growth.  |  Guo, D., et al. 2016. Int J Cancer. 139: 2056-67. PMID: 27434219
  12. MIF/CD74 axis is a target for novel therapies in colon carcinomatosis.  |  Bozzi, F., et al. 2017. J Exp Clin Cancer Res. 36: 16. PMID: 28114961
  13. Macrophage migration inhibitory factor (MIF) inhibitor 4-IPP downregulates stemness phenotype and mesenchymal trans-differentiation after irradiation in glioblastoma multiforme.  |  Lee, SH., et al. 2021. PLoS One. 16: e0257375. PMID: 34516577
  14. Destabilization of macrophage migration inhibitory factor by 4-IPP reduces NF-κB/P-TEFb complex-mediated c-Myb transcription to suppress osteosarcoma tumourigenesis.  |  Zheng, L., et al. 2022. Clin Transl Med. 12: e652. PMID: 35060345
  15. 4-Iodo-6-phenylpyrimidine (4-IPP) suppresses fibroblast-like synoviocyte- mediated inflammation and joint destruction associated with rheumatoid arthritis.  |  Sun, W., et al. 2023. Int Immunopharmacol. 115: 109714. PMID: 36657337

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

4-IPP, 10 mg

sc-361082
10 mg
$210.00

4-IPP, 50 mg

sc-361082A
50 mg
$822.00